Trademark: 88950318
Word
CYTOVALE
Status Date
Monday, December 11, 2023
Filing Date
Friday, June 5, 2020
Published for Opposition
Tuesday, September 14, 2021
Abandoned Date
Monday, December 11, 2023
44 medical services; medical treatment of sepsis, cancer and immune-mediated diseases; medical analysis services in the fields of cytometry, oncology, and hematology
10 medical diagnostic apparatus for analysis of biomarker levels and/or relative expression of host response genes, medical diagnostic apparatus for analyzing gene expression tests using bioinformatics and machine learning algorithms, medical diagnostic apparatus for analyzing gene expression tests, gene expression profiling assays, genetic information, protein biomarkers, clinical data and/or demographic information to aid treatment decisions; sample preparation devices in the nature of lyse wash assistant being automated sample preparation instruments capable of lysing, washing, mixing, and fixing samples that are then ready for analysis on a flow cytometer TQ-prep workstations for standardizing whole blood lysis for flow cytometric analysis and related recorded data management software sold as a unit; diagnostic test apparatus for medical use for analysis of gene expression, protein expression, metabolite expression, inflammation, immune- suppression, immune disorders; medical and diagnostic apparatus for medical use in analysis of gene expression tests, analysis of gene expression profiling assays, analyzing genetic information, analyzing and detecting protein biomarkers, analyzing clinical data, and/or analyzing demographic information; point of care medical devices, namely, polymerase chain reaction (pcr) testing equipment for analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders; medical testing kits for cancer and other immune-mediated conditions; apparatus for diagnostic purposes, namely, medical diagnostic apparatus for testing for cancer and other immune-mediated conditions in the fields of oncology and hematology; ultraviolet visible and near infrared fluorescence analyzers for medical use and components therefor; imaging platforms, namely, medical imaging apparatus for imaging and analysis of cells and cell organelles, molecular diagnostics and imaging cytometry for medical use; medical apparatuses for the examination and analysis of proteins, peptides, antibodies and molecules for medical diagnostic use and components therefor; diagnostic apparatus for medical use, namely, computed tomography scanners, fluorescent microscope systems comprised of optical detection modalities, magnification objective for use in performing fluorescent antibody technique analysis and fluorescent protein technique analysis, automatic cell sorting systems comprised of single-cell analysis, optical detection modalities, electrical detection modalities, mechanical detection modalities for use in flow cytometry analysis and in fluorescence activated cell sorting; flow cytometers
Jun 9, 2020
New Application Entered
Jun 29, 2020
New Application Office Supplied Data Entered
Sep 16, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 9, 2020
Assigned To Examiner
Sep 15, 2020
Non-Final Action Written
Sep 15, 2020
Non-Final Action E-Mailed
Sep 15, 2020
Notification Of Non-Final Action E-Mailed
Sep 16, 2020
Teas Change Of Correspondence Received
Sep 16, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 11, 2021
Correspondence Received In Law Office
Feb 11, 2021
Teas Response To Office Action Received
Feb 12, 2021
Teas/Email Correspondence Entered
Feb 20, 2021
Final Refusal Written
Feb 20, 2021
Final Refusal E-Mailed
Feb 20, 2021
Notification Of Final Refusal Emailed
Aug 12, 2021
Examiners Amendment -Written
Aug 12, 2021
Examiner's Amendment Entered
Aug 12, 2021
Examiners Amendment E-Mailed
Aug 12, 2021
Notification Of Examiners Amendment E-Mailed
Aug 26, 2021
Notification Of Notice Of Publication E-Mailed
Aug 12, 2021
Approved For Pub - Principal Register
Aug 26, 2021
Notification Of Notice Of Publication E-Mailed
Aug 26, 2021
Notification Of Notice Of Publication E-Mailed
Sep 14, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 14, 2021
Published For Opposition
Sep 14, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 14, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 9, 2021
Noa E-Mailed - Sou Required From Applicant
May 2, 2022
Teas Request To Divide Received
May 2, 2022
Divisional Request Received
May 9, 2022
Sou Teas Extension Received
May 9, 2022
Sou Extension 1 Filed
May 14, 2022
Case Assigned To Intent To Use Paralegal
May 19, 2022
Divisional Processing Complete
May 19, 2022
Sou Extension 1 Granted
May 20, 2022
Corrected Noa E-Mailed
Nov 2, 2022
Sou Extension 2 Filed
May 20, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 2, 2022
Sou Teas Extension Received
Nov 5, 2022
Notice Of Approval Of Extension Request E-Mailed
May 8, 2023
Sou Teas Extension Received
May 8, 2023
Sou Extension 3 Filed
Nov 4, 2022
Sou Extension 2 Granted
Jan 17, 2023
Assigned To Examiner
May 8, 2023
Sou Extension 3 Granted
May 10, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 11, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 11, 2023
Abandonment - No Use Statement Filed
Trademark Alertz updated from USPTO on 2030-01-24
